supreme court tirzepatide Legal Challenge Over Lilly's GLP-1 Shortages Highlights FDA's Post-Chevron Vulnerability FDA says the tirzepatide weight-loss
Description
Weights feel heavier
Despite its efficacy in glycemic control and weight reduction, several factors prompt patients to consider discontinuation
These are compounds found in some plants that have weak estrogen-like activity and are found in soy (tofu, edamame, soybeans, soy milk), flaxseed, whole grains, and tea
In the small intestine, it increases the secretion of incretin hormones (like GLP-1) in response to nutrient ingestion
